These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1071671

  • 1. Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
    Rosei EA, Trust PM, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI.
    Clin Sci Mol Med Suppl; 1976 Dec; 3():497s-499s. PubMed ID: 1071671
    [Abstract] [Full Text] [Related]

  • 2. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM, Rosei EA, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [Abstract] [Full Text] [Related]

  • 3. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Rosei EA, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI, Trust PM.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
    Cummings AM, Brown JJ, Fraser R, Lever AF, Morton JJ, Richards DA, Robertson JI.
    Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
    [Abstract] [Full Text] [Related]

  • 5. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B.
    Postgrad Med J; 1980 Oct; 56 Suppl 2():65-8. PubMed ID: 7433346
    [Abstract] [Full Text] [Related]

  • 6. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
    Weber MA, Drayer JI, Kaufman CA.
    J Clin Pharmacol; 1984 Oct; 24(2-3):103-12. PubMed ID: 6143765
    [Abstract] [Full Text] [Related]

  • 7. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A, Lardoux H, Corvol P, Milliez P.
    Nouv Presse Med; 1980 Sep 27; 9(35):2565-8. PubMed ID: 7001349
    [Abstract] [Full Text] [Related]

  • 8. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ, Armstrong BK, Nassim MA, Beilin LJ.
    Br J Clin Pharmacol; 1976 Aug 27; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [Abstract] [Full Text] [Related]

  • 9. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ, Nassim M, Armstrong BK, Beilin L.
    Br J Clin Pharmacol; 1979 Jan 27; 7(1):63-8. PubMed ID: 367410
    [Abstract] [Full Text] [Related]

  • 10. Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo.
    Pugsley D, Armstrong B, Nassim M, Beilin LJ.
    Clin Sci Mol Med Suppl; 1976 Dec 27; 3():501s-503s. PubMed ID: 1071672
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A, Allonen H, Kleimola T.
    Int J Clin Pharmacol Biopharm; 1979 Feb 27; 17(2):71-5. PubMed ID: 422304
    [Abstract] [Full Text] [Related]

  • 12. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ, Wing LM, Mulligan J, Walkley J, Grygiel JJ, Graham JR, Chalmers JP.
    Med J Aust; 1980 Mar 08; 1(5):224-5. PubMed ID: 6990215
    [Abstract] [Full Text] [Related]

  • 13. Emergency treatment of severe hypertension with intravenous labetalol.
    McGrath BP, Matthews PG, Walter NM, Maydom BW, Johnston CI.
    Med J Aust; 1978 Oct 21; 2(9):410-1. PubMed ID: 732728
    [Abstract] [Full Text] [Related]

  • 14. Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
    Prichard BN, Thompson FO, Boakes AJ, Joekes AM.
    Clin Sci Mol Med Suppl; 1975 Jun 21; 2():97s-100s. PubMed ID: 802650
    [Abstract] [Full Text] [Related]

  • 15. Effect of increasing doses of labetalol on blood pressure, plasma renin activity and aldosterone in hypertensive patients.
    Salvetti A, Pedrinelli R, Sassano P, Arzilli F.
    Clin Sci (Lond); 1979 Dec 21; 57 Suppl 5():401s-404s. PubMed ID: 396086
    [Abstract] [Full Text] [Related]

  • 16. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 17. Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
    Hunyor SN, Bauer GE, Ross M, Larkin H.
    Aust N Z J Med; 1980 Apr 26; 10(2):162-6. PubMed ID: 6930206
    [Abstract] [Full Text] [Related]

  • 18. Labetalol in the treatment of hypertension in patients with normal and impaired renal function.
    Walstad RA, Berg KJ, Wessel-Aas T, Nilsen OG.
    Acta Med Scand Suppl; 1982 Apr 26; 665():135-41. PubMed ID: 6961760
    [Abstract] [Full Text] [Related]

  • 19. Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients.
    Lijnen PJ, Amery AK, Fagard RH, Reybrouck TM, Moerman EJ, De Schaepdryver AF.
    J Cardiovasc Pharmacol; 1979 Apr 26; 1(6):625-32. PubMed ID: 94628
    [Abstract] [Full Text] [Related]

  • 20. Effects of labetalol and propranolol on the peripheral circulation in hypertensive patients.
    Nyberg G, Berglund G.
    Acta Med Scand Suppl; 1982 Apr 26; 665():93-101. PubMed ID: 6961763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.